Clinical trials in Huddinge – page 29

745 clinical trials in Huddinge, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Huddinge at a glance

745

clinical trials

Research sites0

Quick filters

745 trials in Huddinge

Open in trial search

End stage renal disease+1

Not yet recruiting

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo

Safety and efficacy of locally administered APAC, heparin sodium and sodium chloride to promote arteriovenous fistula maturation in patients with end‑stage kidney disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Heparin Sodium
Sponsor:Aplagon Oy

Contact Research Centre

Cardiovascular disorder+3

Not yet recruiting

Effect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis

Registered drugNo placebo

Effect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Karolinska University Hospital

Contact Research Centre

Pulmonary embolism

Not yet recruiting

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo

Reduced-dose versus full-dose alteplase for high-risk acute pulmonary embolism patients: a randomized multicenter trial

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Alteplase
Sponsor:University Of Gothenburg

Contact Research Centre

A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

Not yet recruiting

Registered drugNo placebo

A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:AZD0120
Sponsor:AstraZeneca AB

Contact Research Centre

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Norwegian University Of Science And Technolology

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational

Sweden

Participants:65+ years
Substances:TML-6
Sponsor:Merry Life Biomedical Co. Ltd.

Contact Research Centre

Sedative therapy

Not yet recruiting

Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

Registered drugNo placebo

Patient‑controlled propofol versus alfentanil and midazolam sedation for adenoma patients undergoing diagnostic and therapeutic colonoscopy: a satisfaction study

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Alfentanil
Sponsor:Karolinska Institutet

Contact Research Centre

Malignant melanoma stage IV+1

Not yet recruiting

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo

Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Momelotinib
Sponsor:Karolinska University Hospital

Contact Research Centre

Adrenogenital syndrome

Not yet recruiting

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo

Sweden

Participants:18–64 years
Substances:Crinecerfont
Sponsor:Neurocrine Biosciences Inc.

Contact Research Centre

Abortion induced

Not yet recruiting

Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

Registered drug

Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

Registered drug

Sweden

Participants:18–64 years
Substances:Mannitol
Sponsor:Karolinska Institutet

Contact Research Centre

Colorectal cancer

Not yet recruiting

Conversion intraperitoneal chemotherapy with oxaliplatin plus drug combination in colorectal cancer with peritoneal metastases unsuitable for upfront surgery or HIPEC

Registered drugNo placebo

Conversion intraperitoneal chemotherapy with oxaliplatin plus drug combination in colorectal cancer with peritoneal metastases unsuitable for upfront surgery or HIPEC

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Uppsala University Hospital

Contact Research Centre

Palliative care

Not yet recruiting

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Region Skane

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Huddinge

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies exploring treatments for heart failure prevention and cardiovascular disease, including investigations into cholesterol metabolism and blood pressure management.

PCSK9 inhibitors and statins research
Heart failure prevention trials
Lipoprotein management studies

Comprehensive research focusing on reducing cardiovascular events and improving patient outcomes.

02 Oncology Studies

Groundbreaking research in blood cancers, including acute myeloid leukemia and multiple myeloma, with innovative therapeutic approaches.

Advanced breast cancer treatments
Leukemia therapy combinations
CAR T Cell therapy trials

Studies evaluating novel treatment combinations and targeted therapies for various cancer types.

03 Neurological Disorders

Clinical investigations focusing on Alzheimer's disease and amyotrophic lateral sclerosis, exploring innovative therapeutic approaches.

Cognitive impairment treatments
ALS survival studies
Inflammatory response research

Studies examining new therapeutic options for progressive neurological conditions.

04 Chronic Conditions

Research initiatives addressing chronic kidney disease, cystic fibrosis, and other long-term health conditions.

Kidney disease management
Diabetes treatment studies
Organ transplant research

Comprehensive studies aimed at improving quality of life for patients with chronic conditions.

Back to Sweden All countries